- Original Article
- Published:
Systemic and myelotoxic effects of single administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in rats
Environmental Health and Preventive Medicine volume 11, pages 136–144 (2006)
Abstract
Objective
Systemic and myelotoxic effects of 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) were examined by the single administration of TBDD by gavage to rats.
Methods
Fifteen Wistar rats of both sexes per group received 0, 10, 30, 100 or 300 μg TBDD/kg body weight. Rats surviving to the scheduled necropsy on Days 2, 7 and 36 after TBDD administration were examined for growth rate, organ weight, hematology, histopathology and adipose tissue levels of TBDD.
Results
Three 300 μg/kg-dosed females died on Days 21, 23 and 27, and exhibited a marked decrease in body weight, severe thymic atrophy, decreased bone marrow hematopoiesis and hemorrhage in the subarachnoid space of brain and spinal cord. TBDD-dosed surviving rats exhibited growth retardation, decreased bone marrow hematopoiesis, decreases in red blood cell counts, hemoglobin concentrations, and hematocrit values, an increase in reticulocytes and decreases in platelet counts, white blood cell counts and eosinophils. These signs suggested TBDD myelotoxicity. Splenic extramedullary hematopoiesis was increased in both sexes given TBDD, whereas atrophy of the splenic white pulp occurred only in TBDD-dosed females. Marked decreases in body weights and the size and weight of the thymus, severe thymic atrophy and death in TBDD-dosed females suggested a wasting syndrome. The adipose tissue level of TBDD culminated on Day 7 and decreased to 20–30% of the Day 7 level on Day 36.
Conclusions
The TBDD-induced effects were characterized by a wasting syndrome and myelotoxicity that appeared at the dose levels of 30 μg/kg and higher and caused death in 300 μg/kg-dosed females.
References
International Programme on Chemical Safety (IPCS). Environmental Health Criteria 205. Polybrominated dibenzo-p-dioxins and dibenzofurans. Geneva: WHO; 1998.
Buser H-R. Polybrominated dibenzofurans and dibenzo-p-dioxins: Thermal reaction products of polybrominated diphenyl ether flame retardants. Environ Sci Technol. 1986; 20: 404–408.
Zelinski V, Lorenz W, Bahadir M. Brominated flame retardants and resulting PBDD/F in accidental fire residues from private residences. Chemosphere. 1993; 27: 1519–1528.
Sakai S, Watanabe J, Honda Y, Takatsuki H, Aoki I, Futamatsu M, et al. Combustion of brominated flame retardants and behavior of its byproducts. Chemosphere. 2001; 42: 519–531.
Brenner KS, Knies H. Formation of polybrominated dibenzofurans (PBDF’s) and-dioxins (PBDD’s) during extrusion production of a polybutyleneterephthalate (PBTP)/glassfibre resin blended with decabromodiphenylether (DBDPE)/Sb2O3: product and workplace analysis. In: Hutzinger O, Fiedler H editors. Organohalogen Compounds. Vol. 2, DIOXIN ’90-SEMINAR Toxicology, Environment, Food, Exposure-Risk. Bayreuth, Germany: Ecoinforma Press; 1990. P. 319–324.
Brenner KS, Knies H. Workplace monitoring of PBDFs and PBDDs during extrusion production and injection molding of a polybutyleneterephthalate (PBTP)/glass fiber/tetrabromobisphenol A carbonate oligomer (BC52*)/Sb2O3-resin; Part II. Chemosphere. 1993; 26: 1953–1963.
Hayakawa K, Takatsuki H, Watanabe I, Sakai S. Polybrominated diphenyl ethers (PBDEs), polybrominated dibenzo-p-dioxins/dibenzofurans (PBDD/Fs) and monobromo-polychlorinated dibenzo-p-dioxins/dibenzofurans (MoBPXDD/Fs) in the atmosphere and bulk deposition in Kyoto, Japan. Chemosphere. 2004; 57: 343–356.
Choi J-W, Fujimaki S, Kitamura K, Hashimoto S, Ito H, Suzuki N, et al. Polybrominated dibenzo-p-dioxins, dibenzofurans, and diphenyl ethers in Japanese human adipose tissue. Environ Sci Technol. 2003; 37: 817–821.
International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 69. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. Lyon: IARC; 1997.
Birnbaum LS, Morrissey RE, Harris MW. Teratogenic effects of 2,3,7,8-tetrabromodibenzo-p-dioxin and three polybrominated dibenzofurans in C57BL/6N mice. Toxicol Appl Pharmacol. 1991; 107: 141–152.
Mason G, Zacharewski T, Denomme MA, Safe L, Safe S. Polybrominated dibenzo-p-dioxins and related compounds: Quantitative in vivo and in vitro structure-activity relationships. Toxicology. 1987; 44: 245–255.
Ivens IA, Löser E, Rinke M, Schmidt U, Neupert M. Toxicity of 2,3,7,8-tetrabromodibenzo-p-dioxin in rats after single oral administration. Toxicology. 1992; 73: 53–69.
Zinkl JG, Vos JG, Moore JA, Gupta BN. Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environ Health Perspect. 1973; 5: 111–118.
Weissberg JB, Zinkl JG. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin upon hemostasis and hematologic function in the rat. Environ Health Perspect. 1973; 5: 119–123.
Gupta BN, Vos JG, Moore JA, Zinkl JG, Bullock BC. Pathologic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environ Health Perspect. 1973; 5: 125–139.
Luster MI, Boorman GA, Dean JH, Harris MW, Luebke RW, Padarathsingh ML, et al. Examination of bone marrow, immunologic parameters and host susceptibility following pre- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Int J Immunopharmacol. 1980; 2: 301–310.
Luster MI, Hong LH, Boorman GA, Clark G, Hayes HT, Greenlee WF, et al. Acute myelotoxic responses in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Appl Pharmacol. 1985; 81: 156–165.
Murante FG, Gasiewicz TA. Hemopoietic progenitor cells are sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice. Toxicol Sci. 2000; 54: 374–383.
Sakai R, Kajiume T, Inoue H, Kanno R, Miyazaki M, Ninomiya Y, et al. TCDD treatment eliminates the long-term reconstitution activity of hematopoietic stem cells. Toxicol Sci. 2003; 72: 84–91.
Harris MW, Moore JA, Vos JG, Gupta BN. General biological effects of TCDD in laboratory animals. Environ Health Perspect. 1973; 5: 101–109.
Seefeld MD, Corbett SW, Keesey RE, Peterson RE. Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 1986; 73: 311–322.
Christian BJ, Inhorn SL, Peterson RE. Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 1986; 82: 239–255.
Nakagaki K, Arito H, Tsuruta H. Changes in sleep-waking rhythms of rats following a single injection of toluene. Ind Health. 1983; 21: 165–174.
Buser H-R. Rapid photolytic decomposition of brominated and brominated/chlorinated dibenzodioxins and dibenzofurans. Chemosphere. 1988; 17: 889–903.
Popp JA, Cattley RC. Hepatobiliary system. In: Haschek WM, Rousseaux CG editors. Handbook of Toxicologic Pathology. CA: Academic Press; 1991. P. 309.
Yamazaki M, Noguchi Y, Tanda M, Shintani S. Statistical methods appropriate for general toxicological studies in rats. Algorithms for multiple comparisons of treatment groups with control. J Takeda Res Lab. 1981; 40: 163–187. (Article in Japanese)
Hamada C, Yoshino K, Abe I, Matsumoto K, Nomura M, Yoshimura I. Detection of an outlier and evaluation of its influence in chronic toxicity studies. Drug Inf J. 1998; 32: 201–212.
Bloom JC, Brandt JT. Toxic responses of the blood. In: Klaassen CD editor. Casarett and Doul’s Toxicology. The Basic Science of Poisons, 6th ed. NY: McGraw-Hill; 2001. P. 403–405.
Schuurman H-J, Krajnc-Franken MAM, Kuper CF, Van Loveren H, Vos JG. Immune system. In: Haschek WM, Rousseaux CG editors. Handbook of Toxicologic Pathology. San Diego, CA: Academic Press Inc.; 1991. P. 421–483.
De Waal EJ, Schuurman H-J, Loeber JG, Van Loveren H, Vos JG. Alterations in the cortical thymic epithelium of rats after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): An (immuno)histological study. Toxicol Appl Pharmacol. 1992; 115: 80–88.
Kamath AB, Xu H, Nagarkatti PS, Nagarkatti M. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol Appl, Pharmacol. 1997; 142: 367–377.
Staples JE, Murante FG, Fiore NC, Gasiewicz TA, Silverstone AE. Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J Immunol. 1998; 160: 3844–3854.
Kedderis LB, Diliberto JJ, Birnbaum LS. Disposition and excretion of intravenous 2,3,7,8-tetrachlorodibenzo-p-dioxin (TBDD) in rats. Toxicol Appl, Pharmacol. 1991; 108: 397–406.
Nagao T, Yamashita K, Golor G, Bittmann H, Körner W, Hagenmaier H, et al. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats. Life Sci. 1996; 58: 325–336.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamamoto, S., Nagano, K., Senoh, H. et al. Systemic and myelotoxic effects of single administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in rats. Environ. Health Prev. Med. 11, 136–144 (2006). https://doi.org/10.1265/ehpm.11.136
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1265/ehpm.11.136